Literature DB >> 17169534

Drug addiction: pathways to the disease and pathophysiological perspectives.

Michel Le Moal1, George F Koob.   

Abstract

Drug addiction is a medical condition, a chronic relapsing disease. As in other domains of experimental medicine, appropriate experimental investigations are needed in order to better understand the disease. However, to understand the diverse facets of drug effects and of the underlying pathophysiology it is necessary to keep in mind the complexity of the psychopathological processes. The main symptoms that characterize addiction correspond to expressions of dysfunctions within specific circuits and regions. Pathways to addiction are numerous and comorbidity and in the real world poly-drug use are common. Some of these aspects will be examined as well as the role of life events and stress. Theoretical considerations will be proposed [see also: Koob, G.F., & Le Moal, M.. 2005a. Neurobiology of Addiction. Elsevier. 570 pp] to account for the stages of the disease from impulse control disorder to compulsive disorders, for affective dynamics and for the relations between the symptoms and pathophysiology.

Entities:  

Mesh:

Year:  2006        PMID: 17169534     DOI: 10.1016/j.euroneuro.2006.10.006

Source DB:  PubMed          Journal:  Eur Neuropsychopharmacol        ISSN: 0924-977X            Impact factor:   4.600


  79 in total

Review 1.  Cognitive effects of Group I metabotropic glutamate receptor ligands in the context of drug addiction.

Authors:  M Foster Olive
Journal:  Eur J Pharmacol       Date:  2010-04-02       Impact factor: 4.432

Review 2.  The need for a behavioural science focus in research on mental health and mental disorders.

Authors:  Hans-Ulrich Wittchen; Susanne Knappe; Gerhard Andersson; Ricardo Araya; Rosa M Banos Rivera; Michael Barkham; Per Bech; Tom Beckers; Thomas Berger; Matthias Berking; Carmen Berrocal; Christina Botella; Per Carlbring; Guy Chouinard; Francesc Colom; Claudio Csillag; Pim Cujipers; Daniel David; Paul M G Emmelkamp; Cecilia A Essau; Giovanni A Fava; Thomas Goschke; Dirk Hermans; Stefan G Hofmann; Wolfgang Lutz; Peter Muris; Thomas H Ollendick; Filip Raes; Winfried Rief; Heleen Riper; Eliana Tossani; Saskia van der Oord; Bram Vervliet; Josep M Haro; Gunter Schumann
Journal:  Int J Methods Psychiatr Res       Date:  2014-01       Impact factor: 4.035

3.  Negative Affect-Related Factors Have the Strongest Association with Prescription Opioid Misuse in a Cross-Sectional Cohort of Patients with Chronic Pain.

Authors:  Gadi Gilam; John A Sturgeon; Dokyoung S You; Ajay D Wasan; Beth D Darnall; Sean C Mackey
Journal:  Pain Med       Date:  2020-02-01       Impact factor: 3.750

Review 4.  Cellular neuroadaptations to chronic opioids: tolerance, withdrawal and addiction.

Authors:  M J Christie
Journal:  Br J Pharmacol       Date:  2008-04-14       Impact factor: 8.739

5.  Person-environment interaction in the prediction of alcohol abuse and alcohol dependence in adulthood.

Authors:  Karl G Hill; J David Hawkins; Jennifer A Bailey; Richard F Catalano; Robert D Abbott; Valerie B Shapiro
Journal:  Drug Alcohol Depend       Date:  2010-03-17       Impact factor: 4.492

6.  The oxytocin analogue carbetocin prevents emotional impairment and stress-induced reinstatement of opioid-seeking in morphine-abstinent mice.

Authors:  Panos Zanos; Polymnia Georgiou; Sherie R Wright; Susanna M Hourani; Ian Kitchen; Raphaëlle Winsky-Sommerer; Alexis Bailey
Journal:  Neuropsychopharmacology       Date:  2013-10-15       Impact factor: 7.853

Review 7.  The behavioral pharmacology of zolpidem: evidence for the functional significance of α1-containing GABA(A) receptors.

Authors:  Amanda C Fitzgerald; Brittany T Wright; Scott A Heldt
Journal:  Psychopharmacology (Berl)       Date:  2014-02-22       Impact factor: 4.530

Review 8.  Divergent regulation of distinct glucocorticoid systems in alcohol dependence.

Authors:  Scott Edwards; Hilary J Little; Heather N Richardson; Leandro F Vendruscolo
Journal:  Alcohol       Date:  2015-04-30       Impact factor: 2.405

9.  Elevated glucocorticoid levels are responsible for induction of tyrosine hydroxylase mRNA expression, phosphorylation, and enzyme activity in the nucleus of the solitary tract during morphine withdrawal.

Authors:  Cristina Núñez; Anna Földes; Domingo Pérez-Flores; J Carlos García-Borrón; M Luisa Laorden; Krisztina J Kovács; M Victoria Milanés
Journal:  Endocrinology       Date:  2009-01-29       Impact factor: 4.736

Review 10.  Event-Related Potentials as Biomarkers of Behavior Change Mechanisms in Substance Use Disorder Treatment.

Authors:  Rebecca J Houston; Nicolas J Schlienz
Journal:  Biol Psychiatry Cogn Neurosci Neuroimaging       Date:  2017-09-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.